“…It is a late inflammation factor that may enlarge inflammatory response by causing elevated levels of other cytokines through stimulating macrophages to synthesize pro-inflammatory cytokines, which induce and promote each other (Yang et al, 2021). Moreover, recently the inhibition of HMGB1 is considered to be a promising therapeutic target for attenuating inflammatory respond (Zhou et al, 2018;Ni et al, 2020;Wang et al, 2020;Hur et al, 2021). Nuclear transcription factor-κB (NF-κB) is a key transcription factor in inflammatory response (Luo et al, 2020).…”